Autonomix Medical, Inc. (NASDAQ:AMIX) Short Interest Down 23.9% in February

Autonomix Medical, Inc. (NASDAQ:AMIX) was the recipient of a significant decline in short interest during the month of February. As of February 28th, there was short interest totalling 75,900 shares, a decline of 23.9% from the February 13th total of 99,700 shares. Approximately 4.4% of the shares of the stock are short sold. Based on an average daily volume of 347,600 shares, the short-interest ratio is presently 0.2 days.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Autonomix Medical stock. Citadel Advisors LLC purchased a new stake in shares of Autonomix Medical, Inc. (NASDAQ:AMIX) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 47,884 shares of the company’s stock, valued at approximately $180,000. Citadel Advisors LLC owned 4.16% of Autonomix Medical at the end of the most recent reporting period. 10.78% of the stock is owned by institutional investors and hedge funds.

Autonomix Medical Stock Down 4.5 %

Shares of AMIX stock opened at $1.90 on Wednesday. The business has a 50-day moving average price of $2.73 and a two-hundred day moving average price of $7.09. Autonomix Medical has a 12-month low of $1.83 and a 12-month high of $75.80. The firm has a market cap of $4.68 million, a P/E ratio of -0.15 and a beta of -5.40.

Autonomix Medical (NASDAQ:AMIX) last released its earnings results on Thursday, February 13th. The company reported ($1.46) earnings per share for the quarter. As a group, research analysts expect that Autonomix Medical will post -10 EPS for the current fiscal year.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.